![]() Disco Pharmaceuticals Disco Pharmaceuticals is a biotechnology company that specializes in cancer treatment solutions. | ![]() Bexion Pharmaceuticals Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments. | Calidi Biotherapeutics Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer. | ![]() OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics. | ![]() Iksuda Therapeutics Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer. | |
Founding Date | Founding Date 2022 | Founding Date 2006 | Founding Date 2014 | Founding Date 2001 | Founding Date 2007 |
Type | Type Private | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Cologne, DE HQ | Locations Covington, US HQ | Locations San Diego, US HQ Bernried, DE | Locations Kawasaki, JP HQ | Locations Newcastle upon Tyne, GB HQ Newton, US |
Employees | Employees 288% increase | Employees 274% increase | Employees 327% increase | Employees 54 | Employees 43 |
Funding | |||||
Latest funding round | Latest funding round $ 21.7m (over 2 years ago) | Latest funding round $ 16.6m (about 7 years ago) | Latest funding round $ 8.2m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 47m (almost 5 years ago) |
Total funding raised | Total funding raised $ 21.7m | Total funding raised $ 16.6m | Total funding raised $ 20m | Total funding raised N/A | Total funding raised $ 47m |

Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.
View companyCalidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer.
View company
OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
View company
Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.
View company